Trial Details
COMPLETEDBasic Information
| Clinical ID | c1882 |
|---|---|
| Identifier | NCT00640809 |
| Trial Title | Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Bowel Diseases, Inflammatory |
| Interventions | DRUG: Celecoxib; OTHER: Placebo; DRUG: Ibuprofen plus Omeprazole |
Participant Information
| Sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
|---|---|
| City | Scottsdale |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-10-03 |
|---|---|
| Primary Completion Date | - |
| Completion Date | 2025-04-04 |